SequelSEC

HeartBeam, Inc. BEATW

Surgical & Medical Instruments & Apparatus · CIK 0001779372 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
Unavailable
Fiscal year ended 2025-12-31
Operating income
-$21.14M
Fiscal year ended 2025-12-31
Free cash flow
-$14.59M
Fiscal year ended 2025-12-31

HeartBeam, Inc. (BEATW) reported net income of -$21.02M for the fiscal year ended 2025-12-31. This page shows 6 annual periods of income statement, balance sheet and cash flow figures normalized from HeartBeam, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Surgical & Medical Instruments & Apparatus.

Income

HeartBeam, Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-31
RevenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Cost of revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Gross profitUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Operating income-$21.14M-$19.89M-$15.31M-$13.03M-$2.28M-$788.00K
Net income-$21.02M-$19.45M-$14.64M-$12.96M-$4.43M-$1.07M
Research & development$13.45M$11.05M$6.80M$5.68M$255.00K$133.00K
Weighted-average diluted sharesshares 33.71Mshares 26.65Mshares 20.33Mshares 8.17Mshares 4.28Mshares 3.65M
Pretax income-$21.02M-$19.45M-$14.64M-$12.96M-$4.43M-$1.07M
Income tax expense$0$0$0$0$0$0
Diluted EPS$-0.62$-0.73$-0.72$-1.59$-1.03$-0.29
Selling, general & administrativeUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
General & administrative$7.69M$8.84M$8.52M$7.35M$2.03M$655.00K
Selling & marketingUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Balance

HeartBeam, Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-31
Cash & equivalents$4.38M$2.38M$16.19M$3.59M$13.19MUnavailable
Total assets$5.84M$3.28M$17.13M$4.04M$14.00M$51.00K
Current assets$4.68M$2.77M$16.82M$4.04MUnavailableUnavailable
Total liabilities$3.24M$1.62M$1.19M$1.66M$588.00K$4.84M
Current liabilities$3.24M$1.62M$1.19MUnavailableUnavailable$4.84M
Total equity incl. NCI$2.60M$1.65M$15.94M$2.37M$13.41M-$4.78M
Temporary (mezzanine) equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Inventory$103.00K$0UnavailableUnavailableUnavailableUnavailable
Accounts receivableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
GoodwillUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debtUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts payable$1.05M$531.00K$556.00KUnavailableUnavailableUnavailable

Cash flow

HeartBeam, Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-31
Operating cash flow-$13.99M-$14.47M-$12.09M-$9.95M-$3.23M-$600.00K
Capital expenditures$600.00K$201.00K$256.00K$0UnavailableUnavailable
Investing cash flow-$600.00K-$201.00K-$256.00K$0UnavailableUnavailable
Financing cash flow$16.59M$866.00K$24.99M$350.00K$16.40M$619.00K
Net change in cash$2.00M-$13.81M$12.64M-$9.60M$13.17M$19.00K
Stock-based compensation$5.15M$4.30M$3.21M$1.12M$192.00K$10.00K
Common dividends paidUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Common share repurchasesUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Depreciation & amortizationUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Derived

HeartBeam, Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-31
Free cash flow-$14.59M-$14.67M-$12.35M-$9.95MUnavailableUnavailable
Gross marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Operating marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
FCF marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
SBC / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Current ratio1.45xUnavailableUnavailableUnavailableUnavailableUnavailable
Revenue YoY growthUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Net marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
R&D / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
CapEx / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debt / equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Effective tax rateUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open BEATW in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-13View SEC filing
10-Q · Filed 2026-05-13View SEC filing
10-K · Filed 2026-03-12View SEC filing
10-Q · Filed 2025-11-13View SEC filing
10-Q · Filed 2025-08-13View SEC filing
10-Q · Filed 2025-05-13View SEC filing

Companies in the same industry

ADGM AEMD ALUR AMIX ANGO ANIK AORT APYX ARAY ATEC ATRC AURX

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.